The administration of supplemental oxygen has long been one of the most common therapies in the treatment of hospitalized patients. Yet, despite its frequency, there has been little scientific information available about what level of oxygen best optimizes clinical outcomes.
Researchers at Vanderbilt University Medical Center have found that the change in a single letter of the genetic code promotes, in a mouse model, the development of inflammation, high blood pressure and resulting kidney damage.
Idiopathic pulmonary fibrosis (IPF) — a chronic, progressive syndrome — is marked by persistent activation and proliferation of fibroblast cells and the pathologic accumulation of extracellular matrix (scar tissue). Most patients die within 3-5 years of diagnosis.
When Mohana Karlekar, MD, was hired in October 2006 as medical director of the adult Palliative Care Program at Vanderbilt University Medical Center, her 10-year goal was to establish a dedicated inpatient Palliative Care Unit (PCU) so clinicians specializing in palliative care could better…
Kevin P. Seitz, MD, MSc, Matthew Semler, MD, MSc, and colleagues evaluated the relationship of race to incidence of hypoxemia and hyperoxemia in 1,024 patients receiving invasive ventilation in the medical ICU between July 2018 and August 2021.
Vanderbilt University Medical Center and Bayer have agreed to continue a strategic research alliance to evaluate new drug candidates for the treatment of kidney diseases
A reduction in dietary carbohydrates improved both symptoms and objective measurements of gastroesophageal reflux disease (GERD) in a randomized controlled trial.
Given the stakes for patients and for public health, experts say current efforts to correct mistaken or outdated penicillin allergy records are destined to spread to more patient care areas at Vanderbilt University Medical Center.
A Veterans Health Administration project that provided resources for lung cancer screening programs increased the number of veterans screened, according to a study published in the September issue of the journal …
Vanderbilt University Medical Center has received a five-year, $5 million grant from the National Cancer Institute to study precancerous lesions and early cancers in the colon, with the goal of developing new ways to prevent colorectal cancer, the nation’s second leading cancer killer.
